Skip to main content
Clinical Trials/NCT03335384
NCT03335384
Withdrawn
Not Applicable

The Relationship Between Pulmonary Function Measures and Transdiaphragmatic Measures in Duchenne Muscular Dystrophy Subjects

University of Minnesota0 sitesMay 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Duchenne Muscular Dystrophy
Sponsor
University of Minnesota
Primary Endpoint
Evaluation of Pdi
Status
Withdrawn
Last Updated
7 years ago

Overview

Brief Summary

A cross-sectional study to explore the relationship between clinically assessed pulmonary function test (PFT) measures and transdiaphragmatic (Pdi) measures in Duchenne muscular dystrophy (DMD) as well as to explore the relationship between sniff nasal inspiratory pressure (SNIP) and transdiaphragmatic (Pdi) measures in Duchenne muscular dystrophy.

Detailed Description

Two small balloons, which are attached to small, flexible tubes, will be put into the esophagus and stomach through your nose. Each balloon is about 2 inches long (deflated) and about the width of a pencil tip. To reduce any discomfort with this procedure, lidocaine gel or spray will be put into the subject's nose and administered to the back of the throat before the balloon. In addition, swallowing water during the procedure will help to reduce any gagging sensation and will assure that the balloon goes into the esophagus. Proper placement of the catheters will be determined using normal tidal breathing against an occluded mouthpiece with a nose clip. Once proper placement is ensured, the catheters will remain in place during your normal PFT maneuvers. Additionally, while the gastric and esophageal balloon catheters are in place, the subject will be asked to perform a maximal sniff maneuver (SNIP) while one nostril is occluded with a plug containing a distal pressure measurement catheter to measure airway pressure. The distal end of the pressure catheter will be connected to a hand held pressure meter to display peak pressure and to provide you visual feedback. This maneuver will be performed 10 times.

Registry
clinicaltrials.gov
Start Date
May 1, 2018
End Date
May 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of Duchenne muscular dystrophy

Exclusion Criteria

  • Inability to follow verbal instructions

Outcomes

Primary Outcomes

Evaluation of Pdi

Time Frame: 1 year

For all subjects Pdi (transdiaphragmatic pressure measures) will be assessed with gastric and esophageal balloons

Secondary Outcomes

  • Evaluation of SNIP(1 year)
  • Evaluation of MEP(1 year)
  • Evaluation of FEF50(1 year)
  • Evaluation of FVC(1 year)
  • Evaluation of FEF25-75(1 year)
  • Evaluation of MIP(1 year)
  • Evaluation of FEV1(1 year)
  • Evaluation of FEFmax(1 year)

Similar Trials